findmyKOL
Clinical trialNCT00419770CompletedPhase 2Interventional

The Deferasirox-AmBisome Therapy for Mucormycosis (DEFEAT Mucor) Study

SponsorLundquist Institute for Biomedical Innovation at Harbor-UCLA Medical CenterEnrollment20Mucormycosis
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is to determine if the addition of the medication, deferasirox, to standard antifungal therapy for the infection, mucormycosis, is safe and effective
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

  • Brad Spellberg, MD

    Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center

    Principal Investigator
    clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • City of Hope National Medical Center

    Duarte, California, United States

  • Ucsf

    San Francisco, California, United States

  • University of Miami

    Miami, Florida, United States

  • Duke University

    Durham, North Carolina, United States

  • Summa Health Systems

    Akron, Ohio, United States

  • Md Anderson Cancer Center

    Houston, Texas, United States

  • Fred Hutchinson Cancer Research Center

    Seattle, Washington, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Amphotericin B →PlaceboDeferasirox →
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Oct 2007
Primary completion
31 Dec 2009
Completion
31 Dec 2010
Last update posted
16 Oct 2023
Registered enrollment
20
Registry id
NCT00419770
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.